Healthcare startup Olive saw a meteoric rise in 2020 and 2021, spurred by the digital health funding boom and the need for automation during the COVID-19 pandemic. In 2021, Olive executives said the company’s enterprise AI was in place at more than 900 hospitals in over 40 U.S. states, including more than 20 of the top 100 U.S. health systems. But, Olive AI has seen an equally dramatic fall as its business operations have been shrinking since last year. The Columbus, Ohio-based company is now selling off its remaining assets and shutting down operations, Olive announced Tuesday. The company sold its clearinghouse and patient access business units to Waystar and its prior authorization business unit to Humata Health.
Read the full article: Once a High-Flying ‘Unicorn,’ Olive AI Sells Two Key Businesses, Winds Down Operations //